Novel Postneoadjuvant Prognostic Breast Cancer Staging SystemDavid J. Winchester, Kimberly H. Allison, William E. Barlow et al.|Journal of Clinical Oncology|2025Cited by 6
Characterization of dynamic changes in tumor-infiltrating lymphocytes (TIL) after neoadjuvant administration of CUE-101, an HPV16 E7-HLA-IL2 fusion protein, to patients with HPV+ locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC).Jesse M. Zaretsky, Sidharth V. Puram, Riley Mullins et al.|Journal of Clinical Oncology|2025Cited by 0